Things moving along well . Safety trial data is in and no adverse reactions were noted . The efficacy trial has also finished , but is double blinded so will take some time to unblind it and evaluate data . Going for a bouble blinded trial on a phase 1 looks like they are confident of good results . A glance at the pics on their web page gives some indication of why they would be confident . Cheers
SBP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
